ReviewMetabolites2025

SMARCB1 Deficiency as a Driver of the Hallmarks of Cancer in Rhabdoid Tumours: Novel Insights into Dysregulated Energy Metabolism, Emerging Targets, and Ongoing Clinical Trials.

Abdul L Shakerdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.